Cashu | Summary | AGEN

HomeWatchlistNewsSignalsPicks

DJI

+0.36%

SPX

+0.22%

IXIC

+0.17%

FTSE

-0.13%

N225

-0.04%

AXJO

-0.79%

HomeWatchlistNewsSignalsPicks

Stocks

0.00 (0.00%)

0.000

USD

At close at --,----

Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

About Us
Careers
Blog
News

Help & Support

Help Center
Contact Us
Pro Support

Legal

Privacy Policy
Terms of Use

Instagram YouTube

© 2024 Cashu PTY LTD.

Overview

Loading chart...

Join our newsletter to keep up to date with us!

Key Stats

Market Cap

157.42M

Dividend Yield

0.00%

P/E Ratio

-0.83

EPS

-10.58

Revenue

103.46M

Avg. Volume

777.11K

About

What does AGEN do?

Agenus, a US-based biotechnology company headquartered in Lexington, specializes in immuno-oncology therapies targeting cancer and infectious diseases, employing 389 staff. Its pipeline includes advanced antibodies and various immunotherapy classes.

Sector

💻 Health Care

IPO

CEO

Employees

Headquarters

Massachusetts, USA

Website

http://agenusbio.com

Recently from Cashu

Agenus Stock Update: Key Developments and Market Insights.

Zydus Lifesciences Acquires Agenus Facilities to Expand Biologics Manufacturing Capabilities

about 1 month ago

Zydus Acquires Agenus Facilities, Expanding into Biologics CDMO Sector

about 1 month ago

Stocks

Health Care

agen

Agenus

AGEN

+0.11 (+1.77%)

6.33

USD

At close at Jul 16, 17:05 UTC